← Back to Search

Behavioural Intervention

VibrantMinds + Standard Care for Alzheimer's Disease

N/A

Recruiting

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (week 0), post-test (week 12), follow-up (week 16)

Awards & highlights

Study Summary

"This trial developed tablet-based games called VibrantMinds to measure cognitive skills in older adults, including those with dementia. The games were found to be engaging and showed potential for improving cognitive abilities. The

Who is the study for?

This trial is for older adults experiencing cognitive challenges due to conditions like Alzheimer's, mild cognitive impairment, or general aging. Participants should be able to engage with tablet-based games and are looking for new ways to assess and potentially enhance their cognitive skills.Check my eligibility

What is being tested?

The study tests 'VibrantMinds,' a series of tablet-based games designed as an innovative approach to measure and improve cognitive functions in older adults. The effectiveness of these serious computer games will be evaluated against traditional assessments.See study design

What are the potential side effects?

Since the intervention involves non-invasive computer games, there are no direct medical side effects expected from participating in this trial. However, participants may experience fatigue or frustration typical of learning new technology or game-related tasks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (week 0), post-test (week 12), follow-up (week 16)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (week 0), post-test (week 12), follow-up (week 16)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week 0), post-test (week 12), follow-up (week 16) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cognition - Global

Secondary outcome measures

Affect

Agitation

Depression

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: VibrantMinds + Standard CareExperimental Treatment1 Intervention

Older adults at long-term care facilities receive the VibrantMinds games in addition to routine standard care administered by the facility and staff.

Group II: Standard CareActive Control1 Intervention

Older adults at long-term care facilities receive routine standard care administered by the facility and staff.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

889 Previous Clinical Trials

384,936 Total Patients Enrolled

Alberta Health servicesOTHER

158 Previous Clinical Trials

649,544 Total Patients Enrolled

CapitalCareUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing efforts to enlist participants for this trial?

"Indeed, information from clinicaltrials.gov implies that this investigation is currently seeking eligible individuals. The trial was initially released on August 3rd, 2022 and last revised on April 10th, 2024. A total of 122 participants are sought from a single designated site."

Answered by AI

What is the current number of individuals undergoing treatment within this medical study?

"Indeed, the details available on clinicaltrials.gov affirm that this investigation is actively seeking eligible participants. The trial was initially listed on August 3rd, 2022 and underwent its latest update on April 10th, 2024. Enrollment aims to reach a total of 122 individuals at a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Open Platform of Serious Games for Cognitive Intervention

2022. "An Open Platform of Serious Games for Cognitive Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06366867.